Buchumschlag

Supplementary Figures and Western Blot Raw Data for Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer

Fuente: Zenodo

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Zhou, Nan
Format:	Recurso digital
Veröffentlicht:	Zenodo 2025
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Reverse Micelles Dually Influence the Efficient Inhibition of the Heat‐Induced Oxidation of Camellia Oil by Epigallocatechin Gallate and Epigallocatechin
von: Guiwei Leng, et al.
Veröffentlicht: (2025)

Photoprotective Effects of Epigallocatechin Gallate on Ultraviolet-Induced Zebrafish and Human Skin Fibroblasts Cells
von: Jie Zhang, et al.
Veröffentlicht: (2024)

Zirconocene‐Catalyzed Esterification Toward Total Synthesis of (–)‐Epigallocatechin Gallate
von: Xirong Liu, et al.
Veröffentlicht: (2025)

Quantifying the Impact of Epigallocatechin Gallate and Piperine on D. tigrina Regeneration
von: Polepalli, Vinil, et al.
Veröffentlicht: (2025)

Epigallocatechin‐Gallate: Unraveling Its Protective Mechanisms and Therapeutic Potential
von: Xiang‐Wen Dong, et al.
Veröffentlicht: (2025)

Targeting Cancer Through Oxidative Stress: The Role of Epigallocatechin Gallate in Reactive Oxygen Species Modulation
von: Emon Mia, et al.
Veröffentlicht: (2026)

Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials
von: Ahmad Mujtaba Noman, et al.
Veröffentlicht: (2025)

Epigallocatechin‐3‐Gallate Suppresses Glioma by Targeting Integrin αvβ3/ FAK / ERK Signaling Axis and Matrix Metalloproteinases
von: Rui Sun, et al.
Veröffentlicht: (2026)

Silibinin‐Loaded Nanoparticles for Drug Delivery in Gastric Cancer: In Vitro Modulating miR‐181a and miR‐34a to Inhibit Cancer Cell Growth and Migration
von: Mohsen Karami Fath, et al.
Veröffentlicht: (2025)

Epigenetic Suppression of miR‐137 Induces RNF4 Expression, Facilitating Wnt Signaling in Colorectal Cancer
von: Yazhou Wu, et al.
Veröffentlicht: (2024)

Evaluation of Circulating miR‐155, miR‐221, miR‐34a, and miR‐143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer
von: Hersh Abdul Ham‐Karim
Veröffentlicht: (2025)

RETRACTION: Epigallocatechin Gallate in Combination With Eugenol or Amarogentin Shows Synergistic Chemotherapeutic Potential in Cervical Cancer Cell Line
Veröffentlicht: (2026)

Epigallocatechin‐3‐Gallate Encapsulated SNEDDS: A Novel Approach for Neuroprotection in Alzheimer’s Disease
von: Biswajit Pal, et al.
Veröffentlicht: (2025)

(‐)‐Epigallocatechin‐3‐Gallate (EGCG) Regulates the Formation of Zein–Ovalbumin Heteroprotein Complex Coacervates
von: Min Huang, et al.
Veröffentlicht: (2026)

Oral Administration of Epigallocatechin Gallate Prevents Air Pollution‐Induced Acute Lung Injury in Mice Via the Induction of Antioxidants
von: Yui Uehara, et al.
Veröffentlicht: (2025)

Effects of Green Tea and Epigallocatechin Gallate on the Transport of Folic Acid by the Proton‐Coupled Folate Transporter
von: Tomoya Narawa, et al.
Veröffentlicht: (2025)

Effect of Epigallocatechin‐3‐Gallate on Depression‐Related Cytokines in Thalassemia Patients: Molecular and Cellular Evaluation
von: Mohammed N. Salman, et al.
Veröffentlicht: (2026)

Figure 3. miRNA expression in patients with progressive disease (group 1) compared with patients with clinical benefit (stable disease + partial response + complete response; group 2). Statistically significant miR expression levels of (A) miR-200b, (B) miR-34a, (C) miR-21, (D) miR-200a and (E) miR-193b. miR, microRNA.
von: Kubeczko, Marcin, et al.
Veröffentlicht: (2024)

Analysis of Colloidal Transport Mechanisms in Western Blotting
von: Carlos Vargas, et al.
Veröffentlicht: (2025)

Localization of Synthetic Manipulations in Western Blot Images
von: Manjunath, Anmol, et al.
Veröffentlicht: (2024)

Retracted: Expression of miR-210, miR-137, and miR-153 in Patients with Acute Cerebral Infarction
von: BioMed Research International
Veröffentlicht: (2024)

Correction to “Epigallocatechin Gallate and Punicalagin Combination Reduces Aβ Aggregation and Promotes Neurogenesis in Adult Zebrafish Brain”
Veröffentlicht: (2026)

The miR‐148/152 Family Suppresses Apoptosis and Necroptosis for Cancer Evasion Through Direct RIPK1 Repression
von: Jingjing Li, et al.
Veröffentlicht: (2026)

The Antipsychotic Drug Aripiprazole Suppresses Colorectal Cancer by Targeting LAMP2a to Induce RNH1/miR‐99a/mTOR‐Mediated Autophagy and Apoptosis
von: Hui‐Fang Hu, et al.
Veröffentlicht: (2024)

miR ‐143 and miR ‐145 in Colorectal Cancer: A Digital Pathology Approach on Expressions and Protein Correlations
von: Erik Nesje Wiik, et al.
Veröffentlicht: (2025)

LncRNA H19 Promotes Gastric Cancer Metastasis via miR‐148‐3p/SOX‐12 Axis
von: Xin Zhang, et al.
Veröffentlicht: (2024)

The LGALS9 / miR ‐491‐5p Axis Regulates CD8 + T Cell Function and Inhibits the Progression of Gastric Cancer
von: Wanzhong Huang, et al.
Veröffentlicht: (2025)

Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway
von: Ahmed M. Samy, et al.
Veröffentlicht: (2024)

Epigallocatechin‐3‐Gallate Provides Hepatoprotection Through Endoplasmic Reticulum Stress/TXNIP/NLRP3 Axis in Paracetamol‐Induced Acute Liver Injury
von: Nagihan Demirtas, et al.
Veröffentlicht: (2025)

Investigation of the Expression Levels of miR ‐383, miR ‐381, and miR ‐141 miRNAs as Diagnostic Biomarkers in Acute Myeloid Leukemia
von: Mayyadah Ali Ahmed AL‐Gburi, et al.
Veröffentlicht: (2026)

RETRACTION: Oxaliplatin Activates P53/miR‐34a/Survivin Axis in Inhibiting the Progression of Gastric Cancer Cells
Veröffentlicht: (2025)

Explainable Artifacts for Synthetic Western Blot Source Attribution
von: Cardenuto, João Phillipe, et al.
Veröffentlicht: (2024)

Epigallocatechin Gallate Alleviates Cisplatin Induced Intestinal Injury in Rats via Inhibiting NRF2/Keap1 Signaling Pathway and Regulating Gut Microbiota and Metabolites
von: Enshuang Xu, et al.
Veröffentlicht: (2025)

Evaluation of High-Performance Polyether Ether Ketone Polymer Treated with Piranha Solution and Epigallocatechin-3-Gallate Coating
von: Mohammed A. Alsmael, et al.
Veröffentlicht: (2024)

RETRACTION : Epigallocatechin‐3‐Gallate Enhances Differentiation of Acute Promyelocytic Leukemia Cells via Inhibition of PML ‐ RARα and HDAC1
Veröffentlicht: (2025)

Epigallocatechin‐3‐Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP / NLRP3 / IL ‐1β Signaling Pathway
von: Yinghui Wang, et al.
Veröffentlicht: (2024)

Therapeutic Potential of miR‐384 in Gastric Cancer: Dual Regulation of Epithelial‐Mesenchymal Transition and Cell Proliferation Through Direct Targeting of CTNNB1
von: Rongjie Huang, et al.
Veröffentlicht: (2025)

Effect and Mechanism of Whey Protein Isolate‐Epigallocatechin Gallate Non‐Covalent Complex on Skeletal Muscle Attenuation in Aging Mice
von: Yan Yang, et al.
Veröffentlicht: (2025)

Functional Evaluations of Soy Yogurt: Influence of Soy Protein Isolate‐Chitosan‐Epigallocatechin Gallate Complexed Microgels on Structure and Tribology
von: Imane Bourouis, et al.
Veröffentlicht: (2026)

Near‐Infrared Induced miR‐34a Delivery from Nanoparticles in Esophageal Cancer Treatment
von: Nick A. Alden, et al.
Veröffentlicht: (2024)